Ticker Scorecard - BCLI Basics Company: Brainstorm Cell Therapeutics Inc. IPO Date: November 1, 2003 Sector: Healthcare Industry: Biotech Market Cap: $9.07M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.40% Avg Daily Range (30 D): $0.05 | 2.67% Avg Daily Range (90 D): $0.08 | 4.83% Institutional Daily Volume Avg Daily Volume: .03M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 20 Avg Trade Size (Sh.) (30 D): 220 Avg Trade Size (Sh.) (90 D): 200 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.62M Avg Inst. Trade (90 D): $.62M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.27M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 53.4K     News Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Apr 9, 2024 @ 10:05 AM Why Biophytis Shares Are Trading Higher By Around ... Source: Avi Kapoor Mar 25, 2024 @ 6:44 PM Why Landos Biopharma Shares Are Trading Higher By ... Source: Avi Kapoor Jan 30, 2024 @ 6:18 PM Why UPS Shares Are Trading Lower By 8%? Here Are O... Source: Avi Kapoor Dec 27, 2023 @ 7:11 PM Why Reneo Pharmaceuticals Shares Are Trading Highe... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.15 $-.51 $-.04 Diluted EPS $2.15 $-.51 $-.04 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -14.23M $ -2.71M $ -2.54M Operating Income / Loss $ -13.31M $ -3.05M $ -2.98M Cost of Revenue $ $ $ Net Cash Flow $ .26M $ -3.3M $ M PE Ratio 0.74     Splits Oct 01, 2024:   15:1 Sep 16, 2014:   15:1 Aug 13, 2003:   1:2